Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: Cellavision Q4 EBITDA Down At SEK 40.8 Mln

Feb 4 (Reuters) - CellaVision AB  CEVI.ST :
    * GOOD PROFITABILITY AND STABILIZATION IN TWO REGIONS ENDED
A YEAR
CHARACTERIZED BY COVID-19
    * Q4 NET SALES DECREASED BY 13% TO SEK 131.0 MILLION (149.8)
    * Q4 EBITDA SEK 40.8 MILLION VERSUS SEK 41.5 MILLION YEAR
AGO
    * BOARD OF DIRECTORS PROPOSES A DIVIDEND OF SEK 0.75 PER
SHARE FOR
2020 (0.00).
    * COVID-19 PANDEMIC ALSO HAD A NEGATIVE IMPACT ON SALES
DURING Q4
OF YEAR, MEANWHILE WE COULD SEE CONTINUED SIGNS OF RECOVERY IN
SEVERAL OF OUR MARKETS

Source text for Eikon:  ID:nMFNxWWgr 
Further company coverage:  CEVI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on CellaVision AB

See all news